Headquarters
Melbourne, AustraliaFounded
2019CEO / Founder
Thomas KellyEmployees
201-500Funding
Series B — $96.6MProducts
1 product listedAvg. AI Score
7.5/10Website
heidihealth.com/Profile updated
Heidi Health was founded in 2019 in Melbourne, Australia, and develops an ambient medical scribe platform that uses artificial intelligence to transcribe patient consultations and generate structured clinical notes. The company was co-founded by Thomas Kelly, a medical doctor, with the goal of reducing the administrative burden on clinicians.
The platform listens to doctor-patient conversations and produces clinical documentation such as SOAP notes, referral letters, and other structured records across a range of medical specialties. Heidi Health markets its product to individual clinicians, clinics, and larger healthcare organizations, and has expanded its user base internationally, including in the United States, United Kingdom, Canada, and New Zealand.
Heidi Health has raised funding across multiple rounds from venture investors, with backers including Blackbird Ventures among others. The company has scaled its headcount and clinician user base significantly since its founding, positioning itself as one of a number of ambient AI scribe vendors competing in the clinical documentation software market.
Dated, source-cited figures. Estimates are marked.
All products by Heidi Health reviewed by our AI panel of experts.
Six independent reviewer personalities assessed Heidi Health's product on their own terms. They landed within 0.9 points of each other, an unusually strong consensus.
Averaged across 1 reviewed product in our catalog. Scores are out of 10.
Who Heidi Health competes with, and how they differ.
The best-capitalised direct rival in ambient clinical documentation, selling top-down to large US health systems with deep Epic integration and revenue-cycle coding as the pitch. Heidi sells bottom-up to individual clinicians and small practices across 100-plus countries, which is why its consultation volume outruns its enterprise logo count.
1 product reviewed on TopReviewedThe incumbent: Nuance DAX Copilot ships through Microsoft enterprise contracts and native Epic distribution, which no startup can match on procurement reach. Heidi competes on price, self-serve onboarding, 110-language coverage and speed of deployment rather than on EHR-vendor relationships.
9 products reviewed on TopReviewedUS ambient AI documentation aimed at large academic and multi-specialty health systems, with coding accuracy and CDI as its differentiator. It overlaps directly with Heidi enterprise motion but has little presence in the UK, Australian and primary-care markets where Heidi is strongest.
1 product reviewed on TopReviewedThe closest structural analogue: a non-US-origin ambient assistant (French) that also scaled through clinician-led adoption and multilingual support before moving upmarket. Both compete for the same European and multi-language deployments; Nabla is more US-focused post-2024 while Heidi leads in the UK and ANZ.
1 product reviewed on TopReviewedVoice-first AI assistant for clinicians that licenses its ambient engine to EHR vendors and health systems as an embedded platform. That partner-led distribution differs from Heidi direct-to-clinician model, but the two collide in US ambulatory practices.
1 product reviewed on TopReviewedCompetes with Heidi second product line rather than its scribe: OpenEvidence is a clinical evidence search tool monetised through pharma advertising. Heidi launched Heidi Evidence in February 2026 explicitly as an ad-free alternative, arguing commercial sponsorship compromises point-of-care decision support.
1 product reviewed on TopReviewedKey milestones in Heidi Health's history, with sources.
Reported in talks to raise more than $100M at a valuation above $1B
The Australian Financial Review reported that Heidi was negotiating with international investors to raise more than $100 million at a valuation exceeding $1 billion, which would give the company unicorn status. The round was not reported as closed.
afr.comFifteen West Midlands NHS trusts jointly procure Heidi
Fifteen NHS trusts in the West Midlands, including Walsall Healthcare, jointly procured Heidi in what the BBC described as the largest NHS rollout of AI voice transcription software. One Dudley clinic cut a patient-letter backlog from six months to 14 days.
bbc.comBeth Israel Lahey Health rolls out Heidi to more than 6,000 providers
The New England integrated delivery network extended Heidi ambient scribing across 14 hospitals and 175 primary care practices following a 1,000-provider pilot in which 89 percent of users rated generated note quality favourably.
hitconsultant.netLaunches Heidi Remote, a 21-gram wearable for clinicians
At a launch event in Port Melbourne, Heidi unveiled its first hardware product: a 21-gram wireless wearable that replaces the smartphone for recording consultations and moves with a clinician between rooms.
forbes.com.auAcquires UK clinical AI company Automedica
Heidi acquired UK healthcare AI platform Automedica on undisclosed terms, gaining UK regulatory capability including access to the MHRA AI Airlock sandbox. It simultaneously launched Heidi Evidence, built in part on Anthropic Claude models, and Heidi Comms.
startupdaily.netSeries B - US$65M led by Point72 Private Investments at a US$465M valuation
Point72 Private Investments led a $65 million Series B (A$98 million) valuing Heidi at $465 million (A$704 million) and taking total funding to nearly $100 million. Blackbird, Headline and Latitude also participated. Heidi reported over two million consults weekly in 110 languages across 116 countries.
hitconsultant.netSeries A top-up - A$26.8M (US$16.6M) led by Headline
US venture firm Headline led a follow-on investment into the 18-month-old Series A, with Local Globe, Anthology (Menlo Ventures and Anthropic), Blackbird, HESTA, Possible Ventures and Archangel Ventures participating.
startupdaily.netHeidi ambient AI medical scribe launches publicly
The clinical documentation product launched in February 2024. Within roughly a year it had been used in more than 20 million patient interactions and was handling about one million consultations a week across five countries.
startupdaily.netSeries A - $10M led by Blackbird Ventures
Blackbird Ventures led a $10 million Series A, joined by Hostplus, HESTA, Wormhole Capital, Archangel Ventures, Possible Ventures and Saniel Ventures. Around 30 clinics and more than 100 GPs were using the platform at the time.
startupdaily.netSeed round - $5M led by Blackbird Ventures
Blackbird Ventures led a $5 million seed round raised under the company pre-pivot name, reported by Startup Daily as Oscar and elsewhere as Oscer. The same entity later rebranded to Heidi.
startupdaily.netFounded in Melbourne as Oscer by Thomas Kelly, Waleed Mussa and Yu Liu
Vascular surgery registrar Dr Thomas Kelly began the venture in 2019 with Waleed Mussa and Yu Liu while training at The Alfred hospital in Melbourne. Their first product, Oscer, was an AI clinical reasoning tool and the direct precursor to the Heidi documentation platform.
forbes.com.auBrowse multi-perspective AI panel reviews across hundreds of AI tools, agents, and platforms. Find the right software with insights from CTO, Developer, Marketer, Finance, and User perspectives.